Author:
Chubenko Viacheslav A,Navmatulya Alexander Y,Gerk Ivan A,Sarmatov Artem A,Egorenkov Vitaliy V,Shelekhova Ksenia A,Zykov Evgeny N,Chernobrivceva Vera V,Volkov Nikita M,Moiseyenko Vladimir M
Publisher
Springer Science and Business Media LLC
Reference18 articles.
1. Cancer statistics, 2023;Siegel RL;CA Cancer J Clin,2023
2. Perioperative atezolizumab plus fluorouracil, leucovorin, oxaliplatin, and docetaxel for resectable esophagogastric cancer: interim results from the randomized, multicenter, phase II/III DANTE/IKF-s633 Trial;Lorenzen S;J Clin Oncol,2024
3. Recent advances in the management of gastric adenocarcinoma patients;Harada K;F1000Res,2018
4. Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade;Le DT;Science,2017
5. Clinical implications of microsatellite instability in early gastric cancer;Kim DG;J Gastric Cancer,2019